| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65862-581-05 | 65862-581 | HUMAN PRESCRIPTION DRUG | Glimepiride | Glimepiride | TABLET | ORAL | 20120629 | N/A | ANDA | ANDA202759 | Aurobindo Pharma Limited | GLIMEPIRIDE | 4 mg/1 | 500 TABLET in 1 BOTTLE (65862-581-05) |
| 65862-581-25 | 65862-581 | HUMAN PRESCRIPTION DRUG | Glimepiride | Glimepiride | TABLET | ORAL | 20120629 | N/A | ANDA | ANDA202759 | Aurobindo Pharma Limited | GLIMEPIRIDE | 4 mg/1 | 250 TABLET in 1 BOTTLE (65862-581-25) |
| 65862-581-99 | 65862-581 | HUMAN PRESCRIPTION DRUG | Glimepiride | Glimepiride | TABLET | ORAL | 20120629 | N/A | ANDA | ANDA202759 | Aurobindo Pharma Limited | GLIMEPIRIDE | 4 mg/1 | 1000 TABLET in 1 BOTTLE (65862-581-99) |
| 65862-579-01 | 65862-579 | HUMAN PRESCRIPTION DRUG | Glimepiride | Glimepiride | TABLET | ORAL | 20120629 | N/A | ANDA | ANDA202759 | Aurobindo Pharma Limited | GLIMEPIRIDE | 1 mg/1 | 100 TABLET in 1 BOTTLE (65862-579-01) |
| 65862-579-05 | 65862-579 | HUMAN PRESCRIPTION DRUG | Glimepiride | Glimepiride | TABLET | ORAL | 20120629 | N/A | ANDA | ANDA202759 | Aurobindo Pharma Limited | GLIMEPIRIDE | 1 mg/1 | 500 TABLET in 1 BOTTLE (65862-579-05) |
| 65862-579-99 | 65862-579 | HUMAN PRESCRIPTION DRUG | Glimepiride | Glimepiride | TABLET | ORAL | 20120629 | N/A | ANDA | ANDA202759 | Aurobindo Pharma Limited | GLIMEPIRIDE | 1 mg/1 | 1000 TABLET in 1 BOTTLE (65862-579-99) |